Tyra Biosciences, Inc

TYRANASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

59.7M

on 2026-06-30, from 52.5M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-09-14. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since. S-3ASR ↗

$150.0M

TD Securities (USA), agreement of 2025-05-16. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

6.38M

Warrants of every class as tagged in the XBRL facts on 2026-03-31. 10-Q ↗

Cash

2.7 quarters

$73.8M on 2026-06-30 ÷ $27.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-09-14	Public offering incl. 9.08M pre-funded	18,157,529	$22.03	$400.0M	424B5 ↗